Innate Pharma Income Statement (2017-2025) | IPHA

Income Statement Dec2017 Dec2018 Jun2019 Dec2019 Jun2020 Dec2020 Jun2021 Dec2021 Jun2022 Dec2022 Jun2023 Dec2023 Jun2024 Dec2024 Jun2025 Dec2025
Shares Outstanding (Entity) (Quarter) 0.08B67.1472.8376.2489.9089.9089.9091.0491.0491.0491.0491.0492.1792.1799.00102.42
Revenue & cost
Revenue (Quarter) 0.08B0.06B0.01B0.02B56.42B0.04B0.06B0.01B0.01B0.00B
Operating items
Amortization - Intangibles (Quarter) -0.05B-0.00B
Research & Development (Quarter) -0.04B-0.09B-0.04B-0.06B-0.02B-0.05B-0.03B-0.06B-0.04B-0.06B-0.03B-0.06B-0.02B-0.05B
Selling, General & Administrative (Quarter) -0.01B-0.03B-0.02B-0.02B-0.02B-0.03B-0.01B-0.03B-0.01B-0.02B-0.01B-0.02B-0.01B-0.02B
Restructuring Costs (Quarter) -0.05B
Other Operating Expenses (Quarter) 0.000.05B0.00B0.00B
Operating Expenses (Quarter) -0.05B-0.12B-0.05B-0.08B-0.05B-0.08B-0.04B-0.08B-0.05B-0.08B-0.04B-0.08B-0.03B-0.07B
Operating Income (Quarter) -0.01B-0.03B-0.05B-0.00B-0.03B-0.03B
EBIT (Quarter) -0.03B-0.01B-0.01B-0.03B-0.05B-0.02B-0.00B-0.01B-0.03B-0.06B-0.03B-0.06B
Non-operating items
Non Operating Income (Quarter) -0.00B-0.00B-0.00B-0.00B
Net income details
EBT (Quarter) -0.02B-0.01B-0.00B-0.03B-0.05B-0.02B-0.00B-0.01B-0.03B-0.06B-0.02B-0.06B
Profit After Tax (Quarter) -0.02B-0.01B-0.07B0.05B-0.06B-0.07B-0.00B-0.01B0.06B-0.06B0.05B-0.06B
Income from Continuing Operations (Quarter) -0.02B-0.01B-0.00B-0.03B-0.05B-0.02B-0.00B-0.01B-0.03B-0.06B-0.02B-0.06B
Consolidated Net Income (Quarter) -0.02B-0.01B-0.07B-0.03B-0.01B-0.00B-0.00B-0.00B-0.01B-0.03B-0.06B-0.02B
Income towards Parent Company (Quarter) -0.02B-0.01B-0.07B-0.03B0.12B-0.00B0.06B-0.00B-0.01B-0.03B-0.06B-0.02B
Net Income towards Common Stockholders (Quarter) -0.02B-0.01B-0.07B-0.03B0.12B-0.00B0.06B-0.00B-0.01B-0.03B-0.06B-0.02B
Additional items
EPS (Basic) (Quarter) -0.35-0.15-0.91-0.341.540.000.77-0.03-0.11-0.35-0.69-0.28
EPS (Diluted) (Quarter) -0.341.550.000.77-0.03-0.11-0.35-0.70-0.28
Shares Outstanding (Quarter) 0.05B0.06B0.06B0.07B0.08B0.08B0.08B0.08B0.08B0.08B0.08B0.08B0.08B0.08B0.09B0.09B
Shares Outstanding (Diluted) (Quarter) 0.08B0.08B0.08B0.08B0.08B0.08B0.08B0.08B0.09B0.09B
EBITDA (Quarter) -0.03B-0.01B-0.01B-0.03B-0.05B-0.02B-0.00B-0.01B-0.03B-0.06B-0.03B-0.06B
Interest Expenses (Quarter) -0.00B-0.01B-0.01B-0.00B-0.00B0.00B-0.00B0.00B-0.00B0.00B-0.00B